These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 11440271)

  • 1. Mutations in the mouse TSH receptor equivalent to human constitutively activating TSH receptor mutations also cause constitutive activity.
    Neumann S; Krohn K; Chey S; Paschke R
    Horm Metab Res; 2001 May; 33(5):263-9. PubMed ID: 11440271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the cAMP and MAPK pathways in the transformation of mouse 3T3 fibroblasts by a TSHR gene constitutively activated by point mutation.
    Du Villard JA; Wicker R; Crespo P; Russo D; Filetti S; Gutkind JS; Sarasin A; Suárez HG
    Oncogene; 2000 Oct; 19(42):4896-905. PubMed ID: 11039907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic potential of a mutant human thyrotropin receptor expressed in FRTL-5 cells.
    Fournes B; Monier R; Michiels F; Milgrom E; Misrahi M; Feunteun J
    Oncogene; 1998 Feb; 16(8):985-90. PubMed ID: 9519872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of five constitutively activating thyrotrophin receptor mutations.
    Wonerow P; Chey S; Führer D; Holzapfel HP; Paschke R
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):461-8. PubMed ID: 11012571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin, like luteinizing hormone (LH) and chorionic gonadotropin (CG), increases cAMP and inositol phosphate levels in cells with recombinant human LH/CG receptor.
    Hidaka A; Minegishi T; Kohn LD
    Biochem Biophys Res Commun; 1993 Oct; 196(1):187-95. PubMed ID: 8216292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutively activating TSH receptor mutations as the cause of toxic thyroid adenoma, multinodular toxic goiter and autosomal dominant non autoimmune hyperthyroidism.
    Paschke R
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():129-32. PubMed ID: 8981020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current standards, variations, and pitfalls for the determination of constitutive TSHR activity in vitro.
    Mueller S; Jaeschke H; Paschke R
    Methods Enzymol; 2010; 485():421-36. PubMed ID: 21050930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of in vitro constitutive activity for four previously reported TSH receptor mutations identified in patients with nonautoimmune hyperthyroidism and hot thyroid carcinomas.
    Jaeschke H; Mueller S; Eszlinger M; Paschke R
    Clin Endocrinol (Oxf); 2010 Dec; 73(6):815-20. PubMed ID: 20846293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of TSH receptor mutations in three families with resistance to TSH.
    Tonacchera M; Di Cosmo C; De Marco G; Agretti P; Banco M; Perri A; Gianetti E; Montanelli L; Vitti P; Pinchera A
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):712-8. PubMed ID: 17697008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotropin receptor mutations as a tool to understand thyrotropin receptor action.
    Wonerow P; Neumann S; Gudermann T; Paschke R
    J Mol Med (Berl); 2001 Dec; 79(12):707-21. PubMed ID: 11862314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and functional characterization of two novel activating thyrotropin receptor mutants in toxic thyroid follicular adenomas.
    Castro I; Lima L; Seoane R; Lado-Abeal J
    Thyroid; 2009 Jun; 19(6):645-9. PubMed ID: 19499991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSH receptor monoclonal antibodies with agonist, antagonist, and inverse agonist activities.
    Sanders J; Miguel RN; Furmaniak J; Smith BR
    Methods Enzymol; 2010; 485():393-420. PubMed ID: 21050929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive activation of the thyrotropin receptor by deletion of a portion of the extracellular domain.
    Zhang ML; Sugawa H; Kosugi S; Mori T
    Biochem Biophys Res Commun; 1995 Jun; 211(1):205-10. PubMed ID: 7779086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A familial thyrotropin (TSH) receptor mutation provides in vivo evidence that the inositol phosphates/Ca2+ cascade mediates TSH action on thyroid hormone synthesis.
    Grasberger H; Van Sande J; Hag-Dahood Mahameed A; Tenenbaum-Rakover Y; Refetoff S
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2816-20. PubMed ID: 17456567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proper targeting and activity of a nonfunctioning thyroid-stimulating hormone receptor (TSHr) combining an inactivating and activating TSHr mutation in one receptor.
    Agretti P; De Marco G; Collecchi P; Chiovato L; Vitti P; Pinchera A; Tonacchera M
    Eur J Biochem; 2003 Sep; 270(18):3839-47. PubMed ID: 12950268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disorders caused by mutations of the thyrotropin receptor].
    Kosugi S
    Nihon Rinsho; 1998 Jul; 56(7):1856-60. PubMed ID: 9702065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning of the cat TSH receptor and evidence against an autoimmune etiology of feline hyperthyroidism.
    Nguyen LQ; Arseven OK; Gerber H; Stein BS; Jameson JL; Kopp P
    Endocrinology; 2002 Feb; 143(2):395-402. PubMed ID: 11796491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and evaluation of constitutively active thyroid stimulating hormone receptor mutations.
    Lado-Abeal J; Quisenberry LR; Castro-Piedras I
    Methods Enzymol; 2010; 484():375-95. PubMed ID: 21036242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activating mutations of the TSH receptor in differentiated thyroid carcinomas.
    Russo D; Arturi F; Schlumberger M; Caillou B; Monier R; Filetti S; Suárez HG
    Oncogene; 1995 Nov; 11(9):1907-11. PubMed ID: 7478621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.